RegPak Launches Herbal Medicine For Cancer Treatment
Netherlands company, RegPak Bio-Pharma today announced its collaboration with Taiwan based firm Meriyana International Biotechnology to sell Chinese herbal medicine for cancer treatment in India, through its Indian subsidiary CanCure.
Announcing this, Parminder Kaur, CEO of RegPak BioPharma said, “Doctors have been shortlisted to undergo training in Taiwan to work in the CanCure Clinics to be set up in Chandigarh and later, various parts of Punjab.”
She said a substantial number of patients suffer from cancer in various areas of Punjab and claimed that the Chinese medicine would be helpful in treating those patients effectively.
Accompanied by the representatives of Meriyana International, Parminder Kaur said the herbal medicine, ‘Chinmanna’, has undergone several clinical trials in Taiwan, and that RegPak would be introducing it very soon in Europe where it has got the approvals to be introduced as compassionate medicine for terminal cancer patients.
Chinmanna is launched for treatment of various types of cancers including breast, stomach, throat, mouth, pancreas, intestinal and spleen cancer, she said.
- Manufacturers Unite in the Battle Against Breast CancerMedical Devices & Pharma
- Thirona’s AI Tech is Creating Individualised Patient CareTechnology & AI
- HPV Vaccine 'Protects Males from Cancers' - Global ReportMedical Devices & Pharma
- Hologic: How Can Technology be Harnessed to Combat Cancer?Technology & AI
Featured Articles
NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system
Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment
A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency